Clinical trials: Bioavailability Study
Healthy
Terbinafine HCl 250 mg Tablet Formulations Under Non-Fasting Conditions
The Purpose of this study os to evaluate the relative bioavailability of the test formulation of terbinafine tablets with an already marketed reference formulation Lamisil® (Novartis Pharmaceuticals), under post-prandial…
- Trial name
- NCT00833664
- Testing
- Terbinafine HCl 250mg tablets, Lamisil® 250 mg Tablets
- Where
- United States
- Volunteers
- 22 people, healthy volunteers welcome
- Sponsor
- Teva Pharmaceuticals USA
Healthy Adults
Comparative Study of Three Different Formulations of Omega-3 (EPA+DHA)
This pilot study aims at comparing the bioavailability of three different formulations of the omega-3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA).
- Trial name
- NCT04159532
- Testing
- MAG-EPA/MAG-DHA, TG-EPA/TG-DHA, EE-EPA/EE-DHA
- Where
- Canada
- Volunteers
- 36 people, healthy volunteers welcome
- Sponsor
- SCF Pharma
Healthy
A Clinical Trial of MK-1403 in Healthy Participants (MK-1403-007)
The purpose of this trial is to learn about a trial medicine called MK-1403. Researchers designed MK-1403 to treat a type of heart and blood vessel disease called atherosclerotic cardiovascular disease (ASCVD).
- Trial name
- NCT07677163
- Testing
- MK-1403 formulation (FM) 1 + additive, MK-1403 FM2 + additive
- Where
- United States
- Volunteers
- 15 people, healthy volunteers welcome
- Sponsor
- Merck Sharp & Dohme LLC
Healthy
Cefdinir Capsules 300 mg, Fasting
This study will compare the relative bioavailability (rate and extent of absorption) of 300 mg Cefdinir Capsules manufactured and distributed by TEVA pharmaceuticals USA with that of OMNICEF® Capsules by CEPH International…
- Trial name
- NCT00835484
- Testing
- Cefdinir Capsules 300 mg, OMNICEF® 300 mg
- Where
- 2 sites in United States
- Volunteers
- 32 people, healthy volunteers welcome
- Sponsor
- Teva Pharmaceuticals USA
Healthy
Alternative 10 mg/mL Liquid Formulation of ACY 1215 (Ricolinostat) in Healthy Subjects
This study will be an open-label, randomized, single dose, 3-period crossover PK study. This study will comprise 3 treatment periods with a 4-day washout between periods.
- Trial name
- NCT02088398
- Testing
- ACY-1215
- Where
- United States
- Volunteers
- 19 people, healthy volunteers welcome
- Sponsor
- Acetylon Pharmaceuticals Incorporated
Healthy
Pharmacokinetics of 3 Formulations of Ibuprofen Suppositories
The purpose of this study is to compare the pharmacokinetic and bioavailability characteristics of two test formulations of ibuprofen for rectal administration with the profile of a marketed reference formulation of ibuprofen 200…
- Trial name
- NCT00921830
- Testing
- ibuprofen
- Where
- Ireland
- Volunteers
- 25 people, healthy volunteers welcome
- Sponsor
- Johnson & Johnson Consumer and Personal Products Worldwide
Healthy
A Bioequivalence Study of Sanchi-Tongshu Capsule (Enteric Coated Pellets)
24 healthy male volunteers are to be assigned to take orally Sanchi-Tongshu Capsule (Enteric coated pellets) and Sanchi-Tongshu Capsule in fasting condition according to a randomized, crossover, self-control method, with…
- Trial name
- NCT02316730
- Testing
- Sanchi-Tongshu Capsule (Enteric coated pellets), Sanchi-Tongshu Capsule
- Where
- China
- Volunteers
- 23 people, healthy volunteers welcome
- Sponsor
- Pharmaceutical Factory of Chengdu HuaSun Group Inc., Ltd.
Healthy
M7583 Relative Bioavailability of Tablet Compared to Powder-in-capsule
This is a Phase I study consisting of 2 parts: Part 1 aims to investigate the relative bioavailability of tablet formulation (test treatment) and Powder in capsule (PiC) formulation (reference treatment) of M7583 under fasted…
- Trial name
- NCT03297983
- Testing
- M7583
- Where
- Germany
- Volunteers
- 18 people, healthy volunteers welcome
- Sponsor
- Merck KGaA, Darmstadt, Germany
Healthy
Bioavailability of BIBR 1048 MS Tablets in Healthy Subjects With or Without Food
Comparative pharmacokinetics of BIBR 1048 MS solution and tablet with or without food
- Trial name
- NCT02170922
- Testing
- BIBR 1048 MS tablet, BIBR 1048 MS solution
- Volunteers
- 6 people, healthy volunteers welcome
- Sponsor
- Boehringer Ingelheim
Effect of Food
Phase I, Open Label,Crossover Food-Effect and Absolute Bioavailability Study of WCK2349 and WCK771 in Healthy Adult Human Volunteers
This study is aimed to ascertain the effect of food on pharmacokinetics of WCK 2349 and determine the absolute bioavailability of WCK 2349 1000 mg (oral, QD dose) with respect to WCK 771 800 mg (intravenous, QD dose).
- Trial name
- NCT01875939
- Testing
- Oral WCK2349, IV WCK771
- Where
- United States
- Volunteers
- 12 people, healthy volunteers welcome
- Sponsor
- Wockhardt
Hereditary Tyrosinemia, Type I
Bioequivalence Study of Two Oral Nitisinone Formulations to Treat Hereditary Tyrosinemia (HT-1)
The purpose of this study is to determine whether Nitisinone 10 mg Tablets (Test Product 1) and Nitisinone 10 mg Tablets 'Baked' for 6 months @ 40°C/75% RH (Test Product 2) are bioequivalent to the reference product Orfadin 10 mg…
- Trial name
- NCT02750345
- Testing
- Nitisinone, Nitisinone Baked Tablet, Orfadin
- Where
- South Africa
- Volunteers
- 24 people, healthy volunteers welcome
- Sponsor
- Cycle Pharmaceuticals Ltd.
Bioavailability of Omega-3s in Military Rations
Bioavailability of Encapsulated Omega-3 Fatty Acids
Omega-3 fatty acids (n-3s), particularly eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), have anti-inflammatory properties and other documented beneficial health effects that could warrant n-3 fortification of combat…
- Trial name
- NCT01940679
- Testing
- encapsulated 600 mg EPA/DHA
- Where
- United States
- Volunteers
- 14 people, healthy volunteers welcome
- Sponsor
- United States Army Research Institute of Environmental Medicine
Biological Availability, Amorphous Solid Dispersions
Bioavailability Mechanistic Study of Hot-Melt Extruded Amorphous Solid Dispersions
It is the aim of the study to investigate the functioning of a drug delivery system (drug-rich particles forming hot-melt extruded amorphous solid dispersions) with respect to mechanisms of bioavailability of poorly soluble drug…
- Trial name
- BEAD (NCT03886766)
- Testing
- Hot-melt extruded amorphous solid dispersion of Efavirenz, Hot-melt extruded amorphous solid dispersion of Efavirenz homogenized to drug rich particles, Efavirenz solution
- Where
- Switzerland
- Volunteers
- 16 people, healthy volunteers welcome
- Sponsor
- University Hospital, Basel, Switzerland
Obesity, Gastric Reflux
The Bioavailability and Effect on Pouch pH of Esomeprazole After Gastric Bypass
The objective of this study is to investigate the effect of Esomeprazol administered in tablets (Esomeprazol MUT Sandoz® 40mg) or in solution (Esomeprazol MUT Sandoz® 40mg in 10ml tap water) on acid production in the gastric…
- Conditions
- Obesity, Gastric Reflux, Ulcer, Gastric
- Trial name
- NCT05320796
- Testing
- upper endoscopy
- Where
- Switzerland
- Volunteers
- 50 people
- Sponsor
- Prof Urs Zingg
Unspecified Adult Solid Tumor, Protocol Specific
Vinorelbine in Treating Patients With Metastatic or Advanced Solid Tumors
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Randomized phase I trial to compare the effectiveness of two different regimens of vinorelbine in…
- Trial name
- NCT00006088
- Testing
- vinorelbine tartrate
- Where
- United States
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
Bioequivalence
A Bioequivalence Study of Two Different Formulations of Olmesartan Medoxomil/ Hydrochlorothiazide After a Single Oral Dose Administration Under Fasting Conditions
This single dose study was designed in accordance with EMA (the European Medicines Agency) regulatory guidelines, with the aim of characterizing the bioavailability of olmesartan medoxomil/ hydrochlorothiazide in the two…
- Trial name
- NCT04138888
- Testing
- Olmesartan Medoxomil/Hydrochlorothiazide 40 Mg/25 Mg film-coated tablets for oral use, Olmetec® Plus 40 Mg/25 Mg film-coated tablets for oral use
- Where
- Canada
- Volunteers
- 32 people, healthy volunteers welcome
- Sponsor
- Pharmtechnology LLC
Graft Versus Host Disease, Stem Cell Transplantation
Voriconazole Pharmacokinetics in Children With Gastrointestinal Graft Versus Host Disease
Determine how much voriconazole is absorbed when the product is given by mouth to children with extensive graft versus host disease after a stem cell transplantation and determine the correct dosing of voriconazole in this…
- Trial name
- NCT00792246
- Testing
- voriconazole
- Where
- United States
- Volunteers
- 5 people
- Sponsor
- Phillip Brian Smith
Healthy
Allicin Bioavailability From Garlic Supplements and Garlic Foods
This study will measure the bioavailability of allicin, the main active compound of garlic, from garlic supplements and garlic foods (raw, cooked, processed) so that supplement manufacturers and clinical investigators know how…
- Trial name
- NCT00874666
- Testing
- crushed garlic clove, garlic powder tablet
- Where
- United States
- Volunteers
- 12 people, healthy volunteers welcome
- Sponsor
- Silliker, Inc.
Relative Bioavailability
A Relative Bioavailability Study of FOR-6219 in Capsule and Tablet Formulations
This is a phase 1, randomised, open-label, three-way, three-period, crossover relative bioavailability study to assess the single-dose pharmacokinetics of FOR-6219 in capsule and tablet formulations in postmenopausal women.
- Trial name
- NCT04686669
- Testing
- FOR-6219 capsule formulation, FOR-6219 tablet formulation
- Where
- United Kingdom
- Volunteers
- 12 people, healthy volunteers welcome
- Sponsor
- Forendo Pharma Ltd
Healthy
A Relative Bioavailability and Bioequivalence Study of Varegacestat in Healthy Participants
This is an open-label, randomized, crossover study to evaluate the relative bioavailability (rBA) and bioequivalence (BE) of a test capsule formulation of varegacestat compared to reference capsules formulation under fasting…
- Trial name
- NCT07610005
- Testing
- Varegacestat Reference Formulation, Varegacestat Test Formulation
- Where
- United States
- Volunteers
- 20 people, healthy volunteers welcome
- Sponsor
- Immunome, Inc.